- Home
- |
- About
- |
- MC-1 for PNPO Deficiency
- |
- Products
- |
- Newsroom
- |
- Investors
- |
- Contact Us
Medicure was founded in 1997 and became a public company in November 1999. The company trades under the symbol MPH on the TSX Venture Exchange. As a U.S focused Specialty Pharma company with established sales of Aggrastat, Medicure carefully monitors opportunities within its own pipeline of products and possible acquisitions of related pharma companies in order to realize long term value.
A conference call will be held on Monday August 17, 2026 at 7:30 a.m. CDT, 8:30 a.m. EDT for our financial results for quarter ended June 30, 2026.

Events, presentations, stock information,
|
EventsView our calendar of upcoming conferences, roadshows and other events, in addition to dates, locations, and further details. |
Presentations/Conference CallsReview our earnings calls, investor conferences, shareholder meetings, and more. |
Stock InformationMedicure Inc. is publicly traded on the TSX Venture Exchange. Find an interactive share price chart for the Medicure Inc. (MPH) stock. |
Quarterly ReportsFind quarterly financial information such as Statement of Income, Balance Sheet, and Statement of Cash flows. |
Annual ReportsFind annual financial information such as Statement of Income, Statement of Financial Position, Statement of Cash Flows and Per share data. |
Investors ContactsFor questions about investor relations, please contact our team. |
Copyright © 2026 Medicure Inc. All Rights Reserved. | Privacy Policy | Your Privacy Choices | Cookie Preferences